International Clinical Trial: Study on Secukinumab Combined with Moisturizer in the Treatment of Psoriasis

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133577) titled 'Study on Secukinumab Combined with Moisturizer in the Treatment of Psoriasis' on Sept. 29.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shanghai Ninth Peoples Hospital,Shanghai JiaoTong University School of Medicine

Condition: This study targets moderate-to-severe plaque psoriasis (involving the trunk or extremities, with PASI >= 3 and body surface area [BSA] >= 3% excluding nails, palms, soles, scalp, and genitals). The primary observed manifestations include scaling erythematous plaques, xerosis and desquamation, increased transepidermal water loss (TEWL), decreased stratum corne...